| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/23/2005 | CN1190394C Pineapplie leaf extract and its preparation method and application |
| 02/23/2005 | CN1190230C Composition for curing angina pectoris |
| 02/23/2005 | CN1190219C Medicine for non-operation treating of hernia |
| 02/23/2005 | CN1190205C Diemailing injection and its preparing process |
| 02/23/2005 | CN1190192C Capsule agent with grape-seed extracts as raw material |
| 02/22/2005 | US6858750 Such as Parkinson's syndrome, Alzheimer's disease, Huntington's disease, retinopathia pigmentosa and mitochondrial encephalomyopathy; preferred are dialkyl fumarate, monoalkyl fumarate and is salts |
| 02/22/2005 | US6858740 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 02/22/2005 | US6858739 Indole and benzimidazole 15-lipoxygenase inhibitors |
| 02/22/2005 | US6858723 Amphiphile cyclodextrins, preparation and use thereof for solubilizing organized systems and incorporating hydrophobic molecules |
| 02/22/2005 | US6858722 Oligomer phosphoramidite compositions and processes for synthesizing the same |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858646 Administering an antioxidative composition comprising pyruvate, at least one antioxidant and at least one lipid. |
| 02/22/2005 | US6858645 Prevention or the treatment of CNS disorders and related medical disturbances comprising effective amount of the salt according dissolving (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5 -carboxamide in an appropriate |
| 02/22/2005 | US6858642 For use in pharmaceutical, skin-protective and cosmetic formulations |
| 02/22/2005 | US6858636 Angiotensin II antagonists for treating cardiovascular disorders, hypertension, congestive heart failure and glaucoma. |
| 02/22/2005 | US6858632 Derivatives of isosorbide mononitrate and its use as vasodilating agents with reduced tolerance |
| 02/22/2005 | US6858628 Substituted cyclic amine metalloprotease inhibitors |
| 02/22/2005 | US6858626 Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 02/22/2005 | US6858624 Comprises 5,8,14-triazatetracyclo(10.3.1.0.0)-hexadeca-2(11),3,5,7,9-penaene groups; for reducing drug addiction, treating Alzheimer's/Parkinson's diseases, and other nervous system disorders |
| 02/22/2005 | US6858622 Cycloalkano-indole and -azaindole derivatives |
| 02/22/2005 | US6858620 For therapy of male erectile dysfunction; female arousal disorder |
| 02/22/2005 | US6858618 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 02/22/2005 | US6858614 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for treating chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 02/22/2005 | US6858612 Use of tetrahydropteridine derivatives as no synthase inhibitors |
| 02/22/2005 | US6858611 Antiarrhythmia agents; cardiovascular disorders |
| 02/22/2005 | US6858610 Autoimmune disease; antiinflammatory agents |
| 02/22/2005 | US6858603 Acetindine derivatives, their preparation and medicaments containing them |
| 02/22/2005 | US6858602 Compounds for the treatment of metabolic disorders |
| 02/22/2005 | US6858597 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 02/22/2005 | US6858581 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity |
| 02/22/2005 | US6858420 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/22/2005 | US6858407 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 02/22/2005 | US6858383 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 02/22/2005 | US6858235 Antioxidant composition and method of preparation thereof |
| 02/22/2005 | US6858228 Compression of drug and adjuvant |
| 02/22/2005 | US6858219 Methods for sterilizing male mammals |
| 02/17/2005 | WO2005014835A1 Use of fak-related non-kinase in the manufacture of a medicament for the inhibition of stenosis and restenosis |
| 02/17/2005 | WO2005014814A2 5’-and 3’-capped aptamers and uses therefor |
| 02/17/2005 | WO2005014576A1 Isoquinolinone derivative, process for producing the same and use thereof |
| 02/17/2005 | WO2005014572A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | WO2005014548A1 Process for producing low-melting crystal of free disopyramide base |
| 02/17/2005 | WO2005014535A1 Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same |
| 02/17/2005 | WO2005014521A1 Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes |
| 02/17/2005 | WO2005014043A1 Chlorthalidone combinations |
| 02/17/2005 | WO2005014042A1 HEART-SLOWING DRUG CONTAINING SHORT-ACTING β BLOCKER AS THE ACTIVE INGREDIENT |
| 02/17/2005 | WO2005014018A1 Pharmaceutical composition comprising plant material or trichilia sp. alone or in association with other plant extracts for the reversion/combat and/or prevention of ventricular fibrillation |
| 02/17/2005 | WO2005014016A1 Compositions containing macrophages and uses thereof |
| 02/17/2005 | WO2005014015A1 Compositions containing macrophages and uses thereof |
| 02/17/2005 | WO2005013998A1 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
| 02/17/2005 | WO2005013986A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | WO2005013966A1 Macrophage activation inhibitor |
| 02/17/2005 | WO2005013938A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 02/17/2005 | WO2005013884A2 Methods for preventing neurological events |
| 02/17/2005 | WO2005013691A1 Use of boranocarbonates for the therapeutic delivery of carbon monoxide |
| 02/17/2005 | WO2004110344A3 New azetidine compounds |
| 02/17/2005 | WO2004103407A3 Composition comprising a pde4 inhibitor and a pde5 inhibitor |
| 02/17/2005 | WO2004093781A3 Podophyllotoxin derivatives as igf-1r inhibitors |
| 02/17/2005 | WO2004091592A3 Methods and compositions to treat myocardial conditions |
| 02/17/2005 | WO2004087132A3 Combination drug therapy for treating hypertension |
| 02/17/2005 | WO2004081046A3 Human monoclonal antibodies against apociii and their use in the therapy of atherosclerosis |
| 02/17/2005 | WO2003106475A8 Process for the preparation of heterocyclyl substituted adenosine derivatives |
| 02/17/2005 | WO2003099192A8 Bis-aromatic alkanols |
| 02/17/2005 | WO2003080568A3 Probucol derivatives |
| 02/17/2005 | WO2003025131A3 Protein modification and maintenance molecules |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | US20050038505 Drug-delivery endovascular stent and method of forming the same |
| 02/17/2005 | US20050038504 Dip coating stent and/or catheter having complex configuration utilizing aqueous latex polymeric emulsions; reducing material loss; customized variable dosing |
| 02/17/2005 | US20050038259 Elastase release inhibitors; such as 19-(1H-tetrazol-5-yl)nonadec-6-en-5-ol |
| 02/17/2005 | US20050038242 Pyrrolothiazine and pyrrolothiazephine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 02/17/2005 | US20050038126 Administering mammal a bicyclo [3.2.1]octan in a double ring system having kaurene structure such as steviol, isosteviol and stevioside; synergistic mixture with soy protein, and/or fiber and/or isoflavone |
| 02/17/2005 | US20050038119 for treatment of neutrofil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bollous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis; prevention and treatment of damages caused by ischemia and reperfusion |
| 02/17/2005 | US20050038101 Substituted 2 5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
| 02/17/2005 | US20050038095 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 02/17/2005 | US20050038084 Phenylalanine enamide derivatives |
| 02/17/2005 | US20050038072 Nitrogeneous cyclic ketone derivative, process for producing the same, and use |
| 02/17/2005 | US20050038069 Tumor necrosis factor antagonist; antiinflammatory agents; such as 2-Cyclopropyl-4-(3,5-dimethyl-4-pyridylmethoxy)-7-methoxy-3H-benzimidazole |
| 02/17/2005 | US20050038061 6-Aminomorphinane derivatives, method for production and use thereof |
| 02/17/2005 | US20050038045 A2B adenosine receptor antagonists |
| 02/17/2005 | US20050038030 For thromboembolic disorder from unstable angina, acute coronary syndrome, myocardial infarction, ischemia, stroke, atherosclerosis |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050038019 Hydroxy substituted amides for the treatment of alzheimer's disease |
| 02/17/2005 | US20050038014 5'-carbamoyl-1,1' biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 02/17/2005 | US20050038012 use in improvement of gastrointestinal blood flow, in treatment of hypertension and in treatment and prophylaxis of cardiac damages induced by adriamycin and comparable anti-cancer drugs |
| 02/17/2005 | US20050038010 Substituted heterocyclic compounds and methods of use |
| 02/17/2005 | US20050038009 1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N-{(R)- alpha -[N-((S)-1-carboxypropyl) carbamoyl]-4-hydroxybenzyl}carbamoylmethoxy)-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine |
| 02/17/2005 | US20050038008 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
| 02/17/2005 | US20050037995 Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
| 02/17/2005 | US20050037971 Use of hepcidin as a regulator of iron homeostasis |
| 02/17/2005 | US20050037968 Peptide leukotriene receptor |
| 02/17/2005 | US20050037494 Using antisense agents to reduce and/or prevention genic expression associated with cardi-vascular complications; gene therapy |
| 02/17/2005 | US20050037376 Sulfatase polypeptide for use in treatment and prevention of microbial infection, cell proliferative, neurodegenerative and cardiovascular disorders |
| 02/17/2005 | US20050037133 On site polymerization of vinylidenefluoride and hexafluoropropolyene to desired thickness, dip coating stent and/or catheter having complex configuration into latex emulsion containing medication; reducing material loss; customized variable dosaging |
| 02/17/2005 | US20050037097 Pyruvate enriched onion extract |
| 02/17/2005 | US20050037095 Compositions enriched in anthocyanins |
| 02/17/2005 | US20050037069 Solid and stable creatine/citric acid composition(s) and compositions carbohydrate(s) or hydrates thereof, method for the production and use thereof |
| 02/17/2005 | US20050037067 3,7-Diazabicyclo [3.3.1]formulations as anti-arrhythmic compounds |
| 02/17/2005 | US20050037049 use of benzyl ester of hyaluronic acid and/or derivatives, in association with other biopolymers and antitumor agents to fill cavities when the tumor have been surgically removed |
| 02/17/2005 | US20050037009 Methods and reagents for protease inhibition |
| 02/17/2005 | US20050036985 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 02/17/2005 | US20050036983 In vivo use of water absorbent polymers |